Resmed Inc. buy Royal Bank of Canada
Start price
30.01.26
/
50%
€222.50
Target price
30.01.27
-
Performance (%)
-11.64%
Price
09:30
€196.60
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.64%. This prediction currently runs until 30.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.282% | 0.282% |
| iShares Core DAX® | 4.244% | 2.864% |
| iShares Nasdaq 100 | 4.890% | 2.814% |
| iShares Nikkei 225® | 9.397% | 7.826% |
| iShares S&P 500 | 3.528% | 1.950% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for RMD provided by MarketBeat